DASSAULT SYSTÈMES ACQUIRES DRUG TRIAL SOFTWARE FIRM

INDUSTRY DESK■ 1 MIN READ

THU, JUL 23, 2026

■ AI-SUMMARIZED FROM 2 SOURCES ▸ TIMELINE

Dassault Systèmes SE is acquiring ArisGlobal, a drug trial software maker, for up to $2 billion. The deal marks the French company's continued expansion into life sciences software.

The acquisition positions Dassault Systèmes to strengthen its portfolio in pharmaceutical and clinical trial management. ArisGlobal provides software solutions for drug development and regulatory compliance, serving pharmaceutical and biotechnology companies worldwide. Dassault Systèmes, known for its 3D design and simulation platforms, has been diversifying beyond manufacturing into life sciences. This move aligns with broader industry trends as software becomes increasingly critical to accelerating drug development timelines and improving trial efficiency. The deal size—potentially reaching $2 billion—reflects the strategic value Dassault places on clinical trial digitalization. ArisGlobal's technology addresses growing demand for cloud-based platforms that streamline complex regulatory processes and data management in pharmaceutical research.

■ SOURCES

► Bloomberg Tech ► Bloomberg Tech

■ SUMMARY WRITTEN BY AI FROM THE LINKS ABOVE

■ MORE FROM THE BIG TECH DESK

P457US, CHINA TO DISCUSS AI SAFETY IN MID-SEPTEMBER TALKS

The United States and China will hold talks in mid-September focused on artificial intelligence safety risks, with Treasury Secretary Scott Bessent leading the U.S. delegation, according to sources briefed on the discussions.

8H AGO— AI Desk

P451APPLE PLANS RECORD PRODUCT LAUNCHES UNDER TERNUS

Apple will unveil a slate of new devices starting September 9 under newly promoted CEO John Ternus, including a foldable iPhone and touchscreen MacBook—marking the company's most ambitious launch schedule since Tim Cook's departure.

12H AGO— Industry Desk

P450VMWARE REFOCUSES ON TRUST AFTER LOSING SMB CONFIDENCE

Broadcom acknowledged it over-emphasized VMware Cloud Foundation, damaging relationships with small and medium businesses. The company is now prioritizing trust and simpler solutions to win back the segment.

13H AGO— Dev Desk

P438GMAIL KILLS 'SEND AS' FOR THIRD-PARTY EMAILS

Google is discontinuing Gmail's "Send as" feature for non-Google email addresses like @yahoo.com and @outlook.com. Users will no longer be able to compose and send messages from external email accounts through Gmail's interface.

15H AGO— AI Desk

◄ BACK TO NEWS

DASSAULT SYSTÈMES ACQUIRES DRUG TRIAL SOFTWARE FIRM

■ MORE FROM THE BIG TECH DESK

■ SUBSCRIBE TO THE DAILY BRIEF